[33C2-33C2];[33D4-33D4];
A set of isogenic deficiency stocks created by FLP-induced recombination between FRT-carrying transgenic insertions; molecularly defined deletion endpoints correspond to initial location of the progenitor insertions. Initial set of 519 isogenic deletions provides 56% genome coverage.
The current Exelixis collection at the Bloomington Stock Center differs from the original described in FBrf0175003 : a significant number were shown not to carry a deletion and have been removed from the collection; a number of stocks have been lost; a number of additional deletions are included that were generated after publication.
33C2;33D4
Breakpoint from FlyBase's release 5 sequence location of progenitor insertion.
The predicted deficiency was not present in the Df(2L)Exel6032 stock at BDSC.
Limits computationally determined from location of progenitor P insertion on genome sequence between P{EP}JhI-21EP1187 and P{lacW}Aats-thrk04203